Patent Assignment
Reel/Frame 061695/0296
Assignment of Assignor's Interest
Recorded: 2022-11-08
Pages: 5
Assignor
JAZZ PHARMACEUTICALS, INC.
Executed: 2020-12-01
Assignee
JAZZ PHARMACEUTICALS IRELAND LIMITED
WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, 4, IRELAND
Covered Property
(1)
Defibrotide for the Prevention and Treatment of Cytokine Release Syndrome and Neurotoxicity Associated with Immunodepletion
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
Assignment of Assignor's Interest
Nov 8, 2022
From: MCMAHON, SARAH; OKI, YASUHIRO
To: JAZZ PHARMACEUTICALS, INC.
Reel/Frame 061695/0288 →
Release of Security Interest
Jun 11, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 067697/0752 →
Assignment of Assignor's Interest
Jul 17, 2024
From: JAZZ PHARMACEUTICALS IRELAND LIMITED
To: RICHARDSON, PAUL G.
Reel/Frame 068005/0895 →